Hero Mask
Hero Mask

ABOUT US

Our team is committed to advancing genomic medicine.

Led by renowned experts in the fields of genomics, epigenetic editing, and drug discovery, we are driven pioneers committed to making the future of genomic medicine real and delivering hope to patients suffering from serious illnesses.

Meet Chroma
  • Team
  • Leadership
  • Founders
  • Board & Advisors
  • Scientific Advisory Board
  • Investors
    • Meet Chroma
    What do you value most about working at Chroma?
    The Chroma team – the opportunity to bring a transformational therapy to patients with this exceptionally creative, committed and collaborative team.
    No Image
    Catherine Stehman-Breen, M.D., M.S.
    Chief Executive Officer
    VIEW BIO
    What made you choose to join the company?
    Chroma is one of those rare companies with that magic mix of an exciting new therapeutic approach to solving big problems in human health and a team- and people-centric culture that is just as exciting!
    No Image
    Jenny Marlowe, Ph.D.
    Chief Development Officer
    VIEW BIO
    What’s the most exciting part about working at Chroma?
    Helping bring an amazing technology to patients and the world.
    No Image
    Noah Goodman
    Chief Business Officer
    VIEW BIO
    How would you describe the company and your work to your friends and family?
    The science at Chroma is cutting edge, and the team is fabulous. Together, we are working to revolutionize treatments for patients living with severe disease, and we are helping each other grow along the way.
    No Image
    Andrea Sarasin, Ph.D.
    Senior Vice President, Strategy & Portfolio Management
    VIEW BIO
    What do you value most about working at Chroma?
    I’m thrilled to be working alongside such remarkably talented, curious and fun people, as we pioneer scientific innovation and revolutionize treatment of genetically driven disease.
    No Image
    Hasit Lunagaria
    Senior Vice President, People and Culture
    VIEW BIO
    How would you describe the company and your work to your friends and family?
    Chroma’s secret sauce of exciting science and a fantastic team will translate to impactful treatments for unmet medical needs.
    Padma Malyala
    Padma Malyala
    Senior Vice President, Technology Development
    VIEW BIO
    What made you choose to join the company?
    It’s an honor to join this dynamic team working at the forefront of science at such a pivotal time for epigenetic editing to advance a new class of genomic medicines and revolutionize the treatment of disease.
    tracyMcGregor
    Tracy McGregor, M.D., M.S.C.I.
    Senior Vice President, Clinical Development
    VIEW BIO
    What made you choose to join the company?
    The opportunity to be part of a talented team working to transform an innovative technology into therapies for patients.
    No Image
    David Litvak, M.B.A.
    Vice President, Technical Operations
    VIEW BIO
    What made you choose to join the company?
    The potential to impact a wide range of patients and disease areas and working with a talented team of genomic medicine pioneers.
    Elena S
    Elena Spanjaard, PhD
    Vice President, Regulatory Affairs
    VIEW BIO
    What made you choose to join the company?
    Exciting science is what attracted me to Chroma. Ultimately, I joined because of the people. I just wanted to be part of that team and build a great company.
    No Image
    Frederic Tremblay, Ph.D.
    Vice President, Preclinical Programs
    VIEW BIO
    No Image
    John Xiong, Ph.D.
    Vice President, Preclinical Pharmacology
    VIEW BIO
    What do you see as the potential impact of Chroma Medicine’s science and therapeutics?
    Chroma is developing the next generation of genomic medicine. There is an elegance to epigenetic editing that I think will make it vastly applicable to treat human disease.
    No Image
    Morgan Maeder, Ph.D.
    Vice President, Platform Technologies
    VIEW BIO
    What makes Chroma Medicine a great place to work?
    The opportunity to work with a fantastic group of colleagues on an impactful technology that has the potential to treat many diseases.
    No Image
    Sahar Abubucker
    Vice President, Data Sciences
    VIEW BIO
    Sarah Voytek
    Sarah Voytek, Ph.D.
    Vice President, Translational Medicine
    VIEW BIO
    What do you see as the potential impact of Chroma Medicine’s science and therapeutics?
    Chroma’s epigenetic editing technology enables next generation therapeutic approaches in the genome editing space and has far-reaching potential for patients living with genetically driven diseases.
    No Image
    Tobias Brambrink, J.D.
    Vice President, Legal & Intellectual Property
    VIEW BIO